96 related articles for article (PubMed ID: 4363710)
1. Stimulated growth of syngeneic tumors at the site of an ongoing delayed-hypersensitivity reaction to tuberculin in BALB-c mice.
Paranjpe MS; Boone CW
J Natl Cancer Inst; 1974 Apr; 52(4):1297-9. PubMed ID: 4363710
[No Abstract] [Full Text] [Related]
2. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
[No Abstract] [Full Text] [Related]
3. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
Paranjpe MS; Boone CW
J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
[No Abstract] [Full Text] [Related]
4. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
Yamada H
Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
[No Abstract] [Full Text] [Related]
5. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
Kataoka T; Tokunaga T; Murohashi T
J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
[TBL] [Abstract][Full Text] [Related]
6. Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guéin (BCG).
Moore M; Lawrence N; Witherow PJ
Eur J Cancer (1965); 1974 Oct; 10(10):673-82. PubMed ID: 4533899
[No Abstract] [Full Text] [Related]
7. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.
Gautam S; Aikat BK
Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048
[No Abstract] [Full Text] [Related]
8. Enhancement of radiation effects by heating of the tumor.
Yerushalmi A; Har-Kedar I
Isr J Med Sci; 1974 Jul; 10(7):772-6. PubMed ID: 4368681
[No Abstract] [Full Text] [Related]
9. Kinetics of the anti-tumor delayed hypersensitivity response in mice with progressively growing tumors: stimulation followed by specific suppression.
Paranjpe MS; Boone CW
Int J Cancer; 1974 Feb; 13(2):179-86. PubMed ID: 4361649
[No Abstract] [Full Text] [Related]
10. Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.
Creau-Goldberg N; Salomon JC
Br J Cancer; 1980 Apr; 41(4):541-52. PubMed ID: 7387852
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes.
Youdim S; Moser M; Stutman O
J Natl Cancer Inst; 1974 Jan; 52(1):193-8. PubMed ID: 4204245
[No Abstract] [Full Text] [Related]
12. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
Chassoux D; Salomon JC
Int J Cancer; 1975 Oct; 16(4):515-25. PubMed ID: 1176205
[TBL] [Abstract][Full Text] [Related]
13. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
Parr IB; Wheeler LE; Alexander P
Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
[TBL] [Abstract][Full Text] [Related]
14. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
15. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
[TBL] [Abstract][Full Text] [Related]
16. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
Shiraishi M; Himeno K; Nomoto K
Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
[TBL] [Abstract][Full Text] [Related]
17. Inhibition and promotion of tumor growth by BCG: evidence for stimulation of humoral enhancing factors by BCG.
Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K
Int J Cancer; 1978 Jan; 21(1):67-71. PubMed ID: 624600
[TBL] [Abstract][Full Text] [Related]
18. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
Kodama T; Sendo F; Kobayashi H
Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
[No Abstract] [Full Text] [Related]
19. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
Liotta LA; Kleinerman J; Saidel GM
Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
